Stock Taper 
UBS ASSET MANAGEMENT AMERICAS INC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 CG Oncology Inc. | CGON | 761.81K | $54.13M |
 Recursion Pharmaceuticals, Inc. | RXRX | 760.13K | $2.79M |
 Essex Property Trust, Inc. | ESS | 757.44K | $220.86M |
 Campbell Soup Company | CPB | 755.17K | $16.82M |
 Peloton Interactive, Inc. | PTON | 754.16K | $4.46M |
 TeraWulf Inc. | WULF | 753.72K | $18.62M |
 Tradeweb Markets Inc. | TW | 753.19K | $75.06M |
 Chewy, Inc. | CHWY | 750.63K | $14.75M |
 BioNTech SE | BNTX | 744.2K | $69.25M |
 Tanger Inc. | SKT | 742.18K | $29.29M |
 Organon & Co. | OGN | 742.01K | $10.05M |
 Nutanix, Inc. | NTNX | 741.36K | $37.78M |
 Patterson-UTI Energy, Inc. | PTEN | 736.88K | $6.76M |
 Kymera Therapeutics, Inc. | KYMR | 736.87K | $84.5M |
 BioMarin Pharmaceutical Inc. | BMRN | 735.72K | $42.1M |
 Genworth Financial, Inc. | GNW | 735.5K | $6.97M |
 Huron Consulting Group Inc. | HURN | 729.06K | $65.73M |
 Old National Bancorp | ONB | 728.3K | $18.86M |
 Alnylam Pharmaceuticals, Inc. | ALNY | 727.85K | $219.1M |
 F5, Inc. | FFIV | 726.84K | $302.34M |